CEGX Team presents at AGBT 2023

CEGX Team presents at AGBT 2023


Representatives from our R&D team presented 3 posters at the Advances in Genome Biology & Technology General Meeting in Hollywood, Florida. 


View the data presented by the team below:

1. Accurate and simultaneous sequencing of genetics and epigenetics in DNA

Cambridge Epigenetix Ltd, UK

View now

2. Profiling genetic and epigenetic changes, at read level, after cellular rejuvenation

Cambridge Epigenetix Ltd, UK
Altos Labs, Cambridge Institute of Science, UK
Centre for Trophoblast Research, University of Cambridge, UK
Epigenetics Programme, Babraham Institute, UK

Welcome Trust Sanger Institute, Hinxton , UK

View now

3. Joint genetic and epigenetic sequencing technology leads to improved genetics compared to existing methylation calling methods

Cambridge Epigenetix , Cambridge, United Kingdom

Broad Institute of MIT and Harvard, Cambridge, MA, USA

View now

Keep reading

cfDNA fragmentomics: the next frontier in genetic testing

By analysing the unique fragmentation patterns of cfDNA, researchers are unlocking new possibilities for early disease detection, including cancer and prenatal testing. This cutting-edge field combines insights from epigenetics and nucleosome positioning to develop sensitive diagnostic tools that could transform healthcare.

Cambridge Epigenetix is now biomodal